热门资讯> 正文
Coherus Oncology定价股票发行以筹集5010万美元
2026-02-13 16:02
- Coherus Oncology (CHRS) has priced an underwritten public offering of 28.6M shares at $1.75 per share.
- The company expects to raise about $50.1M in gross proceeds before fees and expenses. Coherus is also giving underwriters a 30-day option to buy up to an additional 4.29M shares at the same price.
- The offering is expected to close around February 17, 2026, subject to standard closing conditions.
- The company plans to use the net proceeds to support the commercialization of LOQTORZI (toripalimab-tpzi), continue clinical development of its pipeline, and fund working capital and other general corporate purposes.
More on Coherus BioSciences
- Coherus Oncology, Inc. (CHRS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Coherus Oncology: A Two-Pronged March With Mid-2026 Implications
- Coherus Oncology announces proposed public offering of common stock
- Coherus, J&J agree to evaluate combination prostate cancer treatment
- Seeking Alpha’s Quant Rating on Coherus BioSciences
推荐文章
美股机会日报 | 特朗普再放豪言！正与伊朗谈判，并收到伊方“大礼”；特斯拉机器人再迎新进展！马斯克称有望明年实现量产
一图看懂 | 单季盈利承压！拼多多Q4营收1239亿元同比增12%，调后净利却下跌12%；高管称“力争三年再造一个拼多多”
财报前瞻 | 美团Q4财报将放榜！大摩、高盛逆势力挺股价，当前美团已严重超跌？
中东战火中金价狂泻11%！创43年最惨周跌，避险逻辑崩塌还是黄金坑？
美股机会日报 | 中东硝烟将散？以官员称美方4月9日结束对伊战争！海力士拟筹资百亿赴美上市，豪掷80亿美元锁定阿斯麦光刻机！
一图看懂 | 连续5个季度破千亿！小米Q4营收1169亿创历史新高；净利大增43.8%至63亿元
无论美伊谈判真假！华尔街已从特朗普引发的五分钟狂飙获得明确信号？
麦格理：紧张局势缓和后布伦特原油底部在每桶85至90美元
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
